These data demonstrate that aberrant expression altering of NT5DC3 and HKDC1 induced by intracellular glucose could be directly modulated by LF, underscoring the potential role of LF in colon cancer therapy. The gene discussed is NT5DC3; the disease is malignant colon neoplasm.